Literature DB >> 14604287

Membranous nephropathy associated with donor lymphocyte infusion following allogeneic bone marrow transplantation.

Yasuhiko Miyazaki1, Yasukiyo Mori, Noriko Kishimoto, Noriaki Matsumoto, Katsuhiro Zen, Ryuichi Amakawa, Yuji Kishimoto, Shirou Fukuhara.   

Abstract

Nephrotic syndrome after hematopoietic stem cell transplantation (HSCT) followed by donor lymphocyte infusion (DLI) has never been described. We report the case of a myelodysplastic syndrome (MDS) patient who developed nephrotic syndrome with membranous nephropathy 18 months after allogeneic HSCT and 4 months after DLI. A 50-year-old woman with MDS underwent allogeneic bone marrow transplantation from her HLA-matched brother. MDS relapsed 55 days after transplantation, donor lymphocytes were infused as adoptive immunotherapy, and complete remission was achieved. Four months after the third DLI, the patient developed nephrotic syndrome with proteinuria up to 9 g/day. Renal biopsy revealed granular deposits of immunoglobulin G along the glomerular basement membrane, and subepithelial electron-dense deposits. A diagnosis of membranous nephropathy was made. For maintenance of the immunotherapeutic effect of DLI, minimum doses of immunosuppressive therapy for decreasing proteinuria were administered, and improvement of nephrotic syndrome and persistent complete remission of MDS were achieved.

Entities:  

Mesh:

Year:  2003        PMID: 14604287     DOI: 10.1007/bf02983805

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  14 in total

1.  Nephrotic syndrome as a clinical manifestation of graft-versus-host disease (GVHD) in a marrow transplant recipient after cyclosporine withdrawal.

Authors:  J S Oliveira; D Bahia; M Franco; C Balda; S Stella; J Kerbauy
Journal:  Bone Marrow Transplant       Date:  1999-01       Impact factor: 5.483

2.  Identification of novel minor histocompatibility antigens responsible for graft-versus-leukemia (GVL) effect on chronic myeloid leukemia: usefulness of determining the clonotype of T cells associated with GVL effect after donor leukocyte infusion.

Authors:  Shinji Nakao
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

3.  Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: indications and dose escalation.

Authors:  S Shiobara; S Nakao; M Ueda; H Yamazaki; S Takahashi; S Asano; H Yabe; S Kato; S Imoto; A Maruta; T Yoshida; H Gondo; Y Morishima; Y Kodera
Journal:  Ther Apher       Date:  2001-02

4.  The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation.

Authors:  David I Marks; Richard Lush; Jamie Cavenagh; Donald W Milligan; Steven Schey; Anne Parker; Fiona J Clark; Linda Hunt; John Yin; Steven Fuller; Elisabeth Vandenberghe; Judith Marsh; Timothy Littlewood; Graeme M Smith; Dominic Culligan; Ann Hunter; Rajesh Chopra; Andrew Davies; Keiren Towlson; Catherine D Williams
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

5.  Membranous nephropathy with graft-versus-host disease in a bone marrow transplant recipient.

Authors:  J A Barbara; A C Thomas; P S Smith; D Gillis; J O Ho; A J Woodroffe
Journal:  Clin Nephrol       Date:  1992-03       Impact factor: 0.975

Review 6.  Membranous glomerulonephritis after haematopoietic cell transplantation for multiple myeloma.

Authors:  L Rossi; F Cardarelli; M L Vampa; C Buzio; G Olivetti
Journal:  Nephron       Date:  2001-07       Impact factor: 2.847

7.  Membranous nephropathy in a bone marrow transplant recipient.

Authors:  C Hiesse; E Goldschmidt; G Santelli; B Charpentier; D Machover; D Fries
Journal:  Am J Kidney Dis       Date:  1988-02       Impact factor: 8.860

8.  Nephrotic syndrome with crescent formation and massive IgA deposition following allogeneic bone marrow transplantation for natural killer cell leukemia/lymphoma.

Authors:  Shinya Kimura; Akeyo Horie; Yoshiyuki Hiki; Chie Yamamoto; Satoru Suzuki; Junya Kuroda; Masayo Deguchi; Gen-ichi Kato; Takahiro Karasuno; Akira Hiraoka; Toshikazu Yoshikawa; Taira Maekawa
Journal:  Blood       Date:  2003-01-23       Impact factor: 22.113

Review 9.  Diffuse proliferative glomerulonephritis after bone marrow transplantation.

Authors:  T Suehiro; K Masutani; M Yokoyama; M Tokumoto; K Tsuruya; K Fukuda; H Kanai; R Katafuchi; Y Nagatoshi; H Hirakata
Journal:  Clin Nephrol       Date:  2002-09       Impact factor: 0.975

10.  Strong association of HLA-DR2 and MT1 with idiopathic membranous nephropathy in Japan.

Authors:  Y Hiki; Y Kobayashi; I Itoh; N Kashiwagi
Journal:  Kidney Int       Date:  1984-06       Impact factor: 10.612

View more
  7 in total

1.  A young woman with oedema.

Authors:  Elena Lazzeri; Giuseppe Stefano Netti; Benedetta Mazzinghi; Calogero Cirami; Maurizio Salvadori; Paola Romagnani
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

2.  Nephrotic syndrome in a child after umbilical-cord-blood transplantation.

Authors:  Joo Hoon Lee; Bo Sang Kwon; Il Soo Ha; Hae Il Cheong; Kyung Chul Moon; Hyo Seop Ahn; Yong Choi
Journal:  Pediatr Nephrol       Date:  2006-06-22       Impact factor: 3.714

3.  Chronic kidney disease after autologous stem cell transplantation: analysis of a single center experience.

Authors:  QiaoYuan Wu; XiaoHong Li; YongRong Lai; ZhiGang Peng; YunHua Liao
Journal:  Int Urol Nephrol       Date:  2014-03-26       Impact factor: 2.370

4.  Treatment with candesartan combined with angiotensin-converting enzyme inhibitor for immunosuppressive treatment-resistant nephrotic syndrome after allogeneic stem cell transplantation.

Authors:  Yuko Osugi; Hiroshi Yamada; Gaku Hosoi; Haruyoshi Noma; Misako Ikemiya; Takefumi Ishii; Masahiro Sako
Journal:  Int J Hematol       Date:  2006-06       Impact factor: 2.490

Review 5.  Target antigens and nephritogenic antibodies in membranous nephropathy: of rats and men.

Authors:  P Ronco; H Debiec
Journal:  Semin Immunopathol       Date:  2007-09-26       Impact factor: 9.623

6.  A boy with membranous nephropathy after allogeneic bone marrow transplantation.

Authors:  Osamu Motoyama; Yumiko Uchino; Mika Tokuyama; Kikuo Iitaka; Akira Ohara
Journal:  Clin Exp Nephrol       Date:  2009-05-09       Impact factor: 2.801

7.  Focal segmental glomerulosclerosis as a complication of graft-versus-host disease.

Authors:  Claudia Fofi; Simona Barberi; Antonella Stoppacciaro; Giorgio Punzo; Paolo Menè
Journal:  Nat Rev Nephrol       Date:  2009-04       Impact factor: 28.314

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.